{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:40:46Z","timestamp":1780101646289,"version":"3.54.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T00:00:00Z","timestamp":1398988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0096623","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T20:40:06Z","timestamp":1399063206000},"page":"e96623","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Silencing Herpes Simplex Virus Type 1 Capsid Protein Encoding Genes by siRNA: A Promising Antiviral Therapeutic Approach"],"prefix":"10.1371","volume":"9","author":[{"given":"Fujun","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiqin","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0714.2007.00586.x","article-title":"Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features*","volume":"37","author":"PG Arduino","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"J Piret","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1586\/eri.12.55","article-title":"Prevention, recognition and management of neonatal HSV infections","volume":"10","author":"JL Robinson","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tim.2012.08.005","article-title":"A cultured affair: HSV latency and reactivation in neurons","volume":"20","author":"AC Wilson","year":"2012","journal-title":"Trends Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrd1065","article-title":"Antiherpesvirus drugs: A promising spectrum of new drugs and drug targets","volume":"2","author":"DM Coen","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States","volume":"296","author":"F Xu","year":"2006","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/infdis\/162.1.244","article-title":"Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation","volume":"162","author":"P Ljungman","year":"1990","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2013.05.001","article-title":"Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis","volume":"58","author":"S Burrel","year":"2013","journal-title":"J Clin Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/infdis\/jis237","article-title":"Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals","volume":"205","author":"M van Velzen","year":"2012","journal-title":"J Infect Dis"},{"key":"ref10","first-page":"115","article-title":"Herpes simplex virus resistance to acyclovir: clinical relevance","volume":"4","author":"JC Pottage","year":"1995","journal-title":"Infect Agents Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.16.1.114-128.2003","article-title":"Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy","volume":"16","author":"TH Bacon","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1099-1654(199707)7:2<107::AID-RMV191>3.0.CO;2-M","article-title":"Capsid assembly and DNA packaging in herpes simplex virus","volume":"7","author":"FL Homa","year":"1997","journal-title":"Rev Med Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/JVI.10.5.1044-1052.1972","article-title":"Proteins specified by herpes simplex virus VIII. Characterization and composition of multiple capsid forms of subtypes 1 and 2","volume":"10","author":"W Gibson","year":"1972","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0092-8674(91)90324-R","article-title":"Liquid-crystalline, phage-like packing of encapsidated DNA in herpes simplex virus","volume":"64","author":"FP Booy","year":"1991","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1128\/JVI.03292-12","article-title":"Analysis of the early steps of herpes simplex virus 1 capsid tegumentation","volume":"87","author":"D Henaff","year":"2013","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nsb1195-1026","article-title":"Assembly of VP26 in herpes simplex virus-1 inferred from structures of wild-type and recombinant capsids","volume":"2","author":"ZH Zhou","year":"1995","journal-title":"Nat Struct Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1073\/pnas.91.12.5652","article-title":"Finding a needle in a haystack: detection of a small protein (the 12-kDa VP26) in a large complex (the 200-MDa capsid of herpes simplex virus)","volume":"91","author":"FP Booy","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/jmbi.1993.1406","article-title":"Structure of the herpes simplex virus capsid. Molecular composition of the pentons and the triplexes","volume":"232","author":"WW Newcomb","year":"1993","journal-title":"J Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/13892010113149990201","article-title":"Capsid Assembly as a Point of Intervention for Novel Anti-viral Therapeutics","volume":"14","author":"V Lingappa","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1101\/gad.880001","article-title":"RNA interference-2001","volume":"15","author":"PA Sharp","year":"2001","journal-title":"Gene Dev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"A Fire","year":"1998","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1016\/S0960-9822(02)00665-6","article-title":"RNA silencing","volume":"12","author":"D Baulcombe","year":"2002","journal-title":"Curr Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"SM Elbashir","year":"2001","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0959-437X(02)00290-3","article-title":"RNAi: nature abhors a double-strand","volume":"12","author":"G Hutvagner","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s11095-013-0971-1","article-title":"Delivery systems and local administration routes for therapeutic siRNA","volume":"30","author":"FT Vicentini","year":"2013","journal-title":"Pharm Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/biot.201100054","article-title":"Current progress of siRNA\/shRNA therapeutics in clinical trials","volume":"6","author":"JC Burnett","year":"2011","journal-title":"Biotech J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcv.2011.06.009","article-title":"Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children","volume":"52","author":"Y Wang","year":"2011","journal-title":"J Clin Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"ref29","first-page":"183","article-title":"Animal virus titration techniques","volume":"178","author":"RM Dougherty","year":"1964","journal-title":"Tech Exp Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2<sup>\u2212\u0394\u0394CT<\/sup> Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcv.2006.08.023","article-title":"Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues","volume":"38","author":"A Weinberg","year":"2007","journal-title":"J Clin Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1442-9071.2011.02668.x","article-title":"SiRNA targeting for ICP4 inhibits HSV-1 replication in retinal pigment epithelial cells","volume":"40","author":"F Duan","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00705-008-0110-1","article-title":"Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA","volume":"153","author":"Z Ren","year":"2008","journal-title":"Arch Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1128\/JVI.78.19.10276-10281.2004","article-title":"Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes","volume":"78","author":"PK Bhuyan","year":"2004","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/JVI.80.2.929-940.2006","article-title":"Functional analysis of the triplex proteins (VP19C and VP23) of herpes simplex virus type 1","volume":"80","author":"ME Okoye","year":"2006","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1099\/0022-1317-77-9-2251","article-title":"Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins","volume":"9)","author":"FJ Rixon","year":"1996","journal-title":"J Gen Virol 77 (Pt"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"12698","DOI":"10.1128\/JVI.05791-11","article-title":"A domain in the herpes simplex virus 1 triplex protein VP23 is essential for closure of capsid shells into icosahedral structures","volume":"85","author":"HS Kim","year":"2011","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1128\/JVI.67.3.1357-1364.1993","article-title":"Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA","volume":"67","author":"P Desai","year":"1993","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/viro.1997.9005","article-title":"Capsids are formed in a mutant virus blocked at the maturation site of the UL26 and UL26.5 open reading frames of herpes simplex virus type 1 but are not formed in a null mutant of UL38 (VP19C)","volume":"242","author":"S Person","year":"1998","journal-title":"Virology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1128\/JVI.74.3.1468-1476.2000","article-title":"ATP-Dependent localization of the herpes simplex virus capsid protein VP26 to sites of procapsid maturation","volume":"74","author":"JH Chi","year":"2000","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1099\/vir.0.83652-0","article-title":"Deletion or green fluorescent protein tagging of the pUL35 capsid component of pseudorabies virus impairs virus replication in cell culture and neuroinvasion in mice","volume":"89","author":"M Krautwald","year":"2008","journal-title":"J Gen Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/JVI.68.4.2442-2457.1994","article-title":"Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins","volume":"68","author":"DR Thomsen","year":"1994","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1099\/0022-1317-75-5-1101","article-title":"Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses","volume":"75","author":"J Tatman","year":"1994","journal-title":"J Gen Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1128\/JVI.68.9.5365-5374.1994","article-title":"The size and symmetry of B capsids of herpes simplex virus type 1 are determined by the gene products of the UL26 open reading frame","volume":"68","author":"P Desai","year":"1994","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/JVI.69.6.3690-3703.1995","article-title":"Assembly of the herpes simplex virus capsid: requirement for the carboxyl-terminal twenty-five amino acids of the proteins encoded by the UL26 and UL26.5 genes","volume":"69","author":"DR Thomsen","year":"1995","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1128\/JVI.68.9.6059-6063.1994","article-title":"Cell-free assembly of the herpes simplex virus capsid","volume":"68","author":"WW Newcomb","year":"1994","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"28059","DOI":"10.1074\/jbc.274.40.28059","article-title":"Replication of Herpes Simplex Virus DNA","volume":"274","author":"IR Lehman","year":"1999","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"a013011","DOI":"10.1101\/cshperspect.a013011","article-title":"Herpes simplex viruses: mechanisms of DNA replication","volume":"4","author":"SK Weller","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/C2RA21464D","article-title":"Natural products as a source of anti-herpes simplex virus agents","volume":"3","author":"MG Zhong","year":"2013","journal-title":"RSC Adv"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/ol300728a","article-title":"A New Nucleoside Analogue with Potent Activity against Mutant sr39 Herpes Simplex Virus-1 (HSV-1) Thymidine Kinase (TK)","volume":"14","author":"GS Sundaram","year":"2012","journal-title":"Org Lett"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMra045004","article-title":"Therapeutic potential of RNA interference","volume":"351","author":"M Stevenson","year":"2004","journal-title":"New Engl J Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mrrev.2004.06.002","article-title":"Know-how of RNA interference and its applications in research and therapy","volume":"567","author":"R Wadhwa","year":"2004","journal-title":"Mutat Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0096623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T09:14:28Z","timestamp":1716714868000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0096623"}},"subtitle":[],"editor":[{"given":"Qiliang","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,2]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0096623","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,2]]}}}